Skip to content

Arrowhead Research ARWR Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
$18.66M+84.3%
Royalty Pharma logo
Royalty PharmaRPRX
$18.49M
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$463.5M-6.0%
Roivant Sciences logo
Roivant SciencesROIV
$107.44M+7.3%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$146.09M-2.8%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$266.8M+13.8%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's operating lease liabilities (total)?
Arrowhead Research (ARWR) reported operating lease liabilities (total) of $107.88M in Q1 2026.
How has Arrowhead Research's operating lease liabilities (total) changed year-over-year?
Arrowhead Research's operating lease liabilities (total) decreased by 5.6% year-over-year, from $114.31M to $107.88M.
What is the long-term trend for Arrowhead Research's operating lease liabilities (total)?
Over 5 years (2020 to 2025), Arrowhead Research's operating lease liabilities (total) has grown at a 39.4% compound annual growth rate (CAGR), from $21.14M to $111.4M.
What does operating lease liabilities (total) mean?
The total value of future payments the company is obligated to make for leased assets like offices or labs.
How do you interpret operating lease liabilities (total)?
An increase indicates expansion of physical footprint or new equipment leases, while a decrease suggests lease expirations or reduced physical capacity.
How does operating lease liabilities (total) compare across companies?
Standard for biotech firms that lease specialized lab facilities rather than owning them outright.